News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlycoMimetics, Inc. (GLYC) Appoints Mark A. Goldberg, M.D. To Board of Directors



7/10/2014 11:21:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlycoMimetics, Inc. (NASDAQ:GLYC) announced today the addition of Mark A. Goldberg, M.D. to its Board of Directors. Dr. Goldberg is Executive Vice President, Medical and Regulatory Strategy at Synageva BioPharma Corporation and holds appointments at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. He is also an Associate Clinical Professor of Medicine at Harvard Medical School.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES